Sam Altman touts ChatGPT’s reaccelerating growth to employees as OpenAI closes in on $100 billion funding
OpenAI CEO Sam Altman told employees that ChatGPT’s monthly growth is back above 10%, as competition ramps up in generative AI.
Big Tech stocks are treading water after $1 trillion sell-off week
AI hyperscalers had a bruising week after investors got jittery about huge expenditure outlooks.
Oracle gains 9%, Microsoft climbs 3% as tech tries to bounce back from $1 trillion sell-off
AI hyperscalers had a bruising week after investors got jittery about huge expenditure outlooks.
S&P is already predicting China’s property slump will be worse than it expected this year
S&P Global Ratings said China’s primary real estate sales will likely drop by 10% to 14% this year, steeper than the decline predicted back in October.
Digital employees, AI bootcamps: America’s oldest bank is spending billions on tech
The race to integrate artificial intelligence is on among the banks. BNY now has 134 “digital employees,” who work alongside humans.
Digital employees, AI bootcamps: America’s oldest bank is spending billions on tech
The race to integrate artificial intelligence is on among the banks. BNY now has 134 “digital employees,” who work alongside humans.
Meta warned EU plans to impose measures on tech giant to reverse WhatsApp AI policy
The move follows the European Commission announcing an investigation in December into whether the social media giant had breached antitrust rules.
NatWest shares fall after $3.7 billion deal to buy one of UK’s largest wealth managers
NatWest’s shares slid Monday after the company announced a £2.7 billion ($3.7 billion) deal to acquire one of the U.K.’s largest wealth managers.
10-year Treasury yield is little changed as investors await busy week of economic data
The 10-year Treasury yield was little changed Monday as investors looked ahead to a flurry of economic data, including the delayed January jobs report.
Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill
Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.
